These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32606935)

  • 61. Machine Learning Identification of Immunotherapy Targets in Low-Grade Glioma Using RNA Sequencing Expression Data.
    Agarwal P; Beale OM; Zhang X; Sandlesh P; Jaman E; Amankulor N
    World Neurosurg; 2022 Jul; 163():e349-e362. PubMed ID: 35390499
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular and clinical characterization of TMEM71 expression at the transcriptional level in glioma.
    Wang KY; Huang RY; Tong XZ; Zhang KN; Liu YW; Zeng F; Hu HM; Jiang T
    CNS Neurosci Ther; 2019 Sep; 25(9):965-975. PubMed ID: 31180187
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of cytokine-predominant immunosuppressive class and prognostic risk signatures in glioma.
    Tian Z; Yang Z; Jin M; Ding R; Wang Y; Chai Y; Wu J; Yang M; Zhao W
    J Cancer Res Clin Oncol; 2023 Nov; 149(14):13185-13200. PubMed ID: 37479756
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.
    Zhang Q; Liu XJ; Li Y; Ying XW; Chen L
    Technol Cancer Res Treat; 2021; 20():15330338211011966. PubMed ID: 34159865
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 66.
    Yang Y; Wang J; Xu S; Lv W; Shi F; Shan A
    Transl Neurosci; 2021 Jan; 12(1):9-19. PubMed ID: 33552590
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CD48 is a key molecule of immunomodulation affecting prognosis in glioma.
    Zou C; Zhu C; Guan G; Guo Q; Liu T; Shen S; Yan Z; Xu X; Lin Z; Chen L; Wu A; Cheng W
    Onco Targets Ther; 2019; 12():4181-4193. PubMed ID: 31213836
    [No Abstract]   [Full Text] [Related]  

  • 68. CDC42-A promising immune-related target in glioma.
    Jiang T; Wang X; Huang J; Chen D
    Front Neurosci; 2023; 17():1192766. PubMed ID: 37476838
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PTX3 mediates the infiltration, migration, and inflammation-resolving-polarization of macrophages in glioblastoma.
    Zhang H; Wang Y; Zhao Y; Liu T; Wang Z; Zhang N; Dai Z; Wu W; Cao H; Feng S; Zhang L; Cheng Q; Liu Z
    CNS Neurosci Ther; 2022 Nov; 28(11):1748-1766. PubMed ID: 35855654
    [TBL] [Abstract][Full Text] [Related]  

  • 70.
    Wang T; Luo Y; Zhang Q; Shen Y; Peng M; Huang P; Zhou Z; Wu X; Chen K
    J Thorac Dis; 2022 Mar; 14(3):729-740. PubMed ID: 35399232
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma.
    Chai RC; Wang N; Chang YZ; Zhang KN; Li JJ; Niu JJ; Wu F; Liu YQ; Wang YZ
    Cancer Cell Int; 2019; 19():155. PubMed ID: 31171919
    [TBL] [Abstract][Full Text] [Related]  

  • 72. High Expression Levels of SIGLEC9 Indicate Poor Outcomes of Glioma and Correlate With Immune Cell Infiltration.
    Xu H; Feng Y; Kong W; Wang H; Feng Y; Zhen J; Tian L; Yuan K
    Front Oncol; 2022; 12():878849. PubMed ID: 35756603
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ancient ubiquitous protein 1 (AUP1) is a prognostic biomarker connected with TP53 mutation and the inflamed microenvironments in glioma.
    Chang PC; Lin YC; Yen HJ; Hueng DY; Huang SM; Li YF
    Cancer Cell Int; 2023 Apr; 23(1):62. PubMed ID: 37029364
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epigenetic Activation of lncRNA MIR155HG Mediated by Promoter Hypomethylation and SP1 is Correlated with Immune Infiltration in Glioma.
    Wu X; Wan Q; Wang J; Hou P; Zhang Q; Wang Q; Lu X
    Onco Targets Ther; 2022; 15():219-235. PubMed ID: 35299997
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of N
    Wang W; Li J; Lin F; Guo J; Zhao J
    Neurosurg Rev; 2021 Feb; 44(1):463-470. PubMed ID: 31938968
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.
    Xia P; Li Q; Wu G; Huang Y
    Cell Mol Neurobiol; 2021 Mar; 41(2):365-375. PubMed ID: 32410107
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
    Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment.
    Wen J; Mao X; Cheng Q; Liu Z; Liu F
    Sci Rep; 2021 Nov; 11(1):22502. PubMed ID: 34795387
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
    Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. RELB: A novel prognostic marker for glioblastoma as identified by population-based analysis.
    Zeng F; Wang K; Huang R; Liu Y; Zhang Y; Hu H
    Oncol Lett; 2019 Jul; 18(1):386-394. PubMed ID: 31289510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.